Sometimes a stock just looks so good you have to buy. InVitro International (IVRO) is tiny, profitable, and debt free. The stock sits at a low after falling from a big rise.
Wednesday, November 30, 2022
Thursday, November 10, 2022
A few days ago DYSL put out a tender offer to buy back 54% of their common at $2.49. I first wrote up the stock at $0.81 and my portfolio has been ugly recently so it feels great to have a win.
I'm not sure yet what to do so let's run through some scenarios.
Monday, October 31, 2022
Just a quick note to all my followers out there that I've deleted my Twitter account. Thanks for reaching out to those who asked if everything is OK. There is no problem and I'm not changing anything in my stock and blog world. I just deleted my account once the new ownership took over since I do not want to support them or be associated in any way.
Please continue to contact me through my email firstname.lastname@example.org and I'll keep posting as always right here. Stayed tuned for more half dead companies with potential to be not completely dead lol
Tuesday, September 27, 2022
Brokerages to Buy Dark Stocks
I wish I had a rosy picture to paint you but alas we have reality to deal with. A year ago in Sept 2021 the new SEC rule went into place, resulting in the destruction of dark stock trading. Every single online brokerage I know of in the US stopped allowing buys in any dark stocks.
This post is a summary of the few brokerages that still allow you to buy non-filing dark stocks.
If anyone has found a solution please comment or send me an email.
Wednesday, August 10, 2022
Keeping the Faith in BDRL
I seek stocks at the bottom: fallen and forgotten. Company problems and perception issues push them down with eventual convergence to a single question: will they survive?
Blonder Tongue Laboratories (BDRL) has no shortage of issues but with a market cap of $1.6m and the stock at an all time low, I'm a buyer.
Tuesday, April 19, 2022
QDLC Finally Comes Through
I first wrote up QDLC in 2015 with the stock at $0.20. It was dark and low, forgotten by the market.
The other day a merger was announced for $2 per share. Unfortunately I can't buy more as the stock is on the Expert Market and I don't have an account that allows buys there. Let's close the book on this one.
Saturday, April 16, 2022
NoName Annual Performance 2021-2022
This was a year of the ball bouncing the wrong way. I am up 1.4%, giving me a 43.8% CAGR since I bought my first stock 9 years ago.
You can read my past annual performance posts here.